The IDIBAPS Management Committee, which met on April 30th, approved the leadership change. Eduard Parellada now leads the Schizophrenia group, taking over from Miquel Bernardo.
Although Bernardo has stepped down from the research group due to retirement, he remains connected to the institute as an emeritus researcher.